Across TCGA pan-cancer cohorts, DNM3OS RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated DNM3OS data layer.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher DNM3OS RNA is associated with worse overall survival. In most high-consensus cancer types, elevated DNM3OS expression acts as an unfavorable survival marker, although some lineages such as UCS and SKCM show a favorable association.
KIRP, UCS, and UVM are the cancer types where DNM3OS RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.